28
Views
19
CrossRef citations to date
0
Altmetric
Case report

Treatment of chromoblastomycosis with terbinafine: A report of four cases

, , &
Pages 121-124 | Received 20 Apr 2004, Accepted 08 Feb 2005, Published online: 12 Jul 2009

References

  • Queiroz-Telles F, McGinnis MR, Salkin I, Graybill JR. Subcutaneous mycoses. Infect Dis Clin North Am. 2003; 17:59–85.
  • Minotto R, Bernardi CD, Mallmann LF, Edelweiss MI, Scroferneker ML. Chromoblastomycosis: A review of 100 cases in the state of Rio Grande do Sul. J Am Acad Dermatol. 2001;44:585–92.
  • Nobrega JP, Rosemberg S, Adami AM, Heins-Vaccari EM, Lacaz Cda S, de Brito T. Fonsecaea pedrosoi cerebral phaeohyphomycosis (‘chromoblastomycosis’): First human culture-proven case reported in Brazil. Rev Inst Med Trop Sao Paulo. 2003;45:217-20.Epub 17 Sep 2003.
  • Poirriez J, Breuillard F, Francois N, Fruit J, Sendid B, Gross S, Dei-Cas E. A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am J Trop Med Hyg. 2000; 63:61–3.
  • Pradinaud R, Bolzinger T. Treatment of chromoblastomy- cosis. J Am Acad Dermatol. 1991; 25 (5 Pt 1): 869–70.
  • Perez A. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses. 1999;42(suppl 2):111-14.
  • Hay RJ. Therapeutic potential of terbinafine in sub- cutaneous and systemic mycoses. Br J Dermatol. 1999; 141(suppl 56):36-40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.